Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Gravol Chewables Motion Sickness Dimenhydrinate
Generic Name
Dimenhydrinate
Active Ingredient
DimenhydrinateCategory
Other
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 50 mg/1 | TABLET, CHEWABLE | ORAL | 10237-943 |
Detailed information about Gravol Chewables Motion Sickness Dimenhydrinate
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Gravol Chewables Motion Sickness Dimenhydrinate, you must consult a qualified healthcare professional.
Dimenhydrinate is a first-generation antihistamine and anticholinergic agent primarily used to prevent and treat symptoms of motion sickness, including nausea, vomiting, and dizziness.
For the prevention or treatment of motion sickness, the standard adult dosage of Dimenhydrinate is 50 mg to 100 mg taken orally every 4 to 6 hours. According to the FDA-approved labeling, the total daily dose for adults should not exceed 400 mg in a 24-hour period. To maximize effectiveness, the initial dose should be administered at least 30 to 60 minutes before starting the activity that causes motion sickness (such as boarding a plane or boat).
Dimenhydrinate must be dosed with extreme caution in children, and parents should always consult a pediatrician before administration. The dosage is typically based on age:
Patients with significant kidney disease (renal impairment) may experience a slower clearance of Dimenhydrinate metabolites. While specific GFR-based (Glomerular Filtration Rate) guidelines are limited, healthcare providers often suggest extending the dosing interval (e.g., every 8-12 hours instead of 4-6) to prevent drug accumulation.
Because Dimenhydrinate is extensively metabolized by the liver, patients with hepatic cirrhosis or liver failure may require lower doses. Reduced liver function can lead to increased plasma concentrations and a higher risk of CNS toxicity and prolonged sedation.
Geriatric patients are particularly sensitive to the anticholinergic effects of Dimenhydrinate. Clinical guidelines, such as the Beers Criteria, often recommend avoiding this drug in the elderly due to the high risk of confusion, dizziness, and falls. If used, the lowest possible dose should be initiated.
Dimenhydrinate can be taken with or without food. Taking it with a small meal or a glass of milk may help reduce potential stomach upset.
Storage: Store Dimenhydrinate at room temperature, between 68°F and 77°F (20°C to 25°C). Keep the medication away from excessive heat, moisture, and direct light. Ensure the container is tightly closed and kept out of reach of children and pets.
If you are taking Dimenhydrinate on a regular schedule and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular timing. Do not 'double up' or take two doses at once to make up for a missed one, as this increases the risk of toxicity.
An overdose of Dimenhydrinate can be serious and potentially life-threatening, especially in children. Signs of overdose include:
In the event of a suspected overdose, contact your local Poison Control Center or seek emergency medical attention immediately. Treatment usually involves supportive care, gastric lavage (stomach pumping) if caught early, and potentially the administration of physostigmine in severe anticholinergic toxicity cases.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency without medical guidance. Excessive use can lead to tolerance or increased side effects.
The most frequently reported side effect of Dimenhydrinate is drowsiness (somnolence). Because the drug crosses the blood-brain barrier and blocks H1 receptors responsible for alertness, many patients feel significant tiredness or a 'foggy' sensation. This effect is often dose-dependent. Other common effects include:
These side effects occur in a smaller percentage of the population but are well-documented in clinical trials:
> Warning: Stop taking Dimenhydrinate and call your doctor or emergency services immediately if you experience any of the following:
Dimenhydrinate is intended for short-term, intermittent use. Prolonged daily use can lead to several complications:
There are currently no FDA Black Box Warnings for Dimenhydrinate. However, the lack of a black box warning does not imply the drug is without risk. It remains a potent CNS depressant and anticholinergic agent that must be used according to labeled instructions.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of side effects is essential to ensure the medication remains safe for your specific physiological profile.
Dimenhydrinate is a potent medication that affects the Central Nervous System (CNS). The most critical safety consideration is the significant impairment of mental alertness and physical coordination. Patients must be aware that the 'drowsiness' associated with this drug is not merely a feeling of tiredness but a functional impairment comparable to alcohol intoxication in some individuals.
No FDA black box warnings for Dimenhydrinate. However, clinical guidelines emphasize that it should be used with extreme caution in pediatric populations due to the risk of respiratory depression and paradoxical CNS stimulation.
For occasional use (e.g., a single flight or boat trip), specialized lab monitoring is usually not required. However, if a healthcare provider prescribes Dimenhydrinate for longer-term management of vestibular disorders, the following may be monitored:
Do not drive, operate heavy machinery, or engage in hazardous activities until you know how Dimenhydrinate affects you. The sedative effects can significantly slow reaction times and impair judgment. Combining Dimenhydrinate with even small amounts of alcohol or other sedatives can create a dangerous level of impairment.
Alcohol must be strictly avoided while taking Dimenhydrinate. Alcohol acts synergistically with the antihistamine to profoundly increase CNS depression. This combination can lead to extreme lethargy, respiratory depression, and an increased risk of accidents or overdose.
For most users who take Dimenhydrinate occasionally for travel, tapering is not necessary. However, for those who have used the drug daily for several weeks, a gradual reduction in dose may be recommended by a doctor to avoid withdrawal-like symptoms such as headache, nausea, and irritability.
> Important: Discuss all your medical conditions, especially respiratory or eye issues, with your healthcare provider before starting Dimenhydrinate.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is the only way to ensure your safety.
In certain clinical scenarios, the risks of Dimenhydrinate significantly outweigh any potential benefits. It must NEVER be used in the following cases:
These conditions require a careful risk-benefit analysis by a healthcare provider:
Patients who are allergic to other ethanolamine-class antihistamines (such as clemastine or carbinoxamine) are at a much higher risk of being allergic to Dimenhydrinate. Additionally, because Dimenhydrinate contains a theophylline derivative, patients with a history of sensitivity to caffeine, theophylline, or aminophylline should use this medication with extreme caution, as they may experience heightened jitteriness or cardiac symptoms.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of eye or prostate issues, before prescribing or recommending Dimenhydrinate.
Dimenhydrinate is generally classified as FDA Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, and there are no adequate and well-controlled studies in pregnant women. While it is often used for 'morning sickness' when other treatments fail, it should only be used during pregnancy if clearly needed and under the direct supervision of an obstetrician. Some studies have suggested that high doses of antihistamines near the end of pregnancy might stimulate uterine contractions, though this is rare with standard doses.
Dimenhydrinate is excreted into breast milk in small amounts. The primary concern is the potential for the drug to cause unusual drowsiness, irritability, or decreased feeding in the nursing infant. Additionally, antihistamines can potentially decrease serum prolactin levels, which might interfere with milk production (lactation) in some women. If use is necessary, the mother should monitor the infant closely for any changes in sleep patterns or behavior.
Dimenhydrinate is approved for use in children as young as 2 years old, but dosing must be precise. It is NOT approved for use in children under 2 years of age due to the risk of fatal respiratory depression. In older children, the most common 'special' reaction is paradoxical excitation. Instead of becoming sleepy, the child may become hyperactive, agitated, and unable to sleep. Parents should be warned of this possibility. Always use the included measuring device for liquid forms to avoid dosing errors.
The elderly (ages 65 and older) are at the highest risk for adverse events from Dimenhydrinate. Age-related declines in liver and kidney function can lead to higher drug concentrations. More importantly, the aging brain is more susceptible to the anticholinergic effects. This can manifest as acute confusion (delirium), increased risk of falls due to dizziness/sedation, and worsening of pre-existing dementia. The American Geriatrics Society (Beers Criteria) identifies Dimenhydrinate as a potentially inappropriate medication for older adults.
In patients with a GFR below 50 mL/min, the clearance of diphenhydramine metabolites is reduced. While not typically requiring a dose reduction for a single use, repeated dosing should be spaced further apart (e.g., every 9-12 hours) to avoid accumulation and CNS toxicity. It is not significantly removed by hemodialysis.
For patients with Child-Pugh Class B or C hepatic impairment, the half-life of Dimenhydrinate can be nearly doubled. Healthcare providers should consider reducing the starting dose by 50% and monitoring closely for signs of excessive sedation or confusion.
> Important: Special populations require individualized medical assessment. Never assume an over-the-counter drug is safe for children, seniors, or pregnant individuals without professional consultation.
Dimenhydrinate is a competitive H1-receptor antagonist. Its primary site of action is the vestibular apparatus in the inner ear. By blocking the H1 receptors in the vestibular nucleus and the solitary nucleus, it prevents the transmission of excitatory signals to the vomiting center in the brain. Its 8-chlorotheophylline component is a xanthine derivative that acts as a mild CNS stimulant and adenosine receptor antagonist, though its primary role in this formulation is to form a stable salt with diphenhydramine.
The onset of the antiemetic effect occurs within 15 to 30 minutes of oral administration. The duration of effect typically lasts 4 to 6 hours, though this can be prolonged in patients with impaired metabolism. Dimenhydrinate does not significantly affect gastric acidity, but it does slow gastric emptying and intestinal motility due to its muscarinic (M3) receptor antagonism.
| Parameter | Value |
|---|---|
| Bioavailability | 40% - 60% (First-pass metabolism) |
| Protein Binding | 78% - 85% |
| Half-life | 3.5 - 9 hours (Adults) |
| Tmax | 1 - 2 hours |
| Metabolism | Hepatic (CYP2D6) |
| Excretion | Renal (95% as metabolites) |
Dimenhydrinate is classified as a first-generation antihistamine, specifically an ethanolamine derivative. It is therapeutically grouped with other anti-motion sickness agents like Meclizine and Scopolamine, though it is generally more sedating than Meclizine and faster-acting than Scopolamine patches.
Common questions about Gravol Chewables Motion Sickness Dimenhydrinate
Dimenhydrinate is primarily used to prevent and treat the symptoms of motion sickness, which include nausea, vomiting, and dizziness. It works by blocking histamine and acetylcholine receptors in the brain's vestibular system, which is responsible for balance. Healthcare providers may also recommend it for the short-term relief of vertigo associated with inner ear conditions. It is most effective when taken before the activity that causes motion sickness begins. Always consult your doctor to ensure it is the appropriate treatment for your specific symptoms.
The most common side effect is significant drowsiness, which affects a large majority of users. Other frequent side effects include dry mouth, blurred vision, and a feeling of thick mucus in the nose or throat. Some individuals may also experience constipation or a slight decrease in coordination. These effects are due to the drug's antihistamine and anticholinergic properties. If these symptoms persist or become bothersome, you should contact your healthcare provider for advice.
No, you should strictly avoid alcohol while taking Dimenhydrinate. Alcohol is a central nervous system depressant that can dangerously multiply the sedative effects of the medication. This combination can lead to extreme lethargy, impaired judgment, and potentially life-threatening respiratory depression. Even small amounts of alcohol can significantly increase the risk of accidents while driving or performing other tasks. Always wait until the medication has completely cleared your system before consuming alcohol.
Dimenhydrinate is generally considered to be in FDA Pregnancy Category B, meaning it is often used when necessary but should only be taken under medical supervision. While it is not known to cause birth defects in humans, every pregnancy is unique, and the risks must be weighed against the benefits. Some doctors may suggest it for severe morning sickness if other safer options have failed. However, you must consult your obstetrician before taking any medication during pregnancy. They will provide the safest dosing schedule for you and your baby.
Dimenhydrinate typically begins to work within 15 to 30 minutes after oral administration. However, it takes about 1 to 2 hours to reach its peak effectiveness in the bloodstream. For this reason, it is highly recommended to take the dose at least 30 to 60 minutes before you start traveling or engaging in an activity that causes motion sickness. If you wait until you are already feeling sick, the medication may take longer to work because your digestion slows down during nausea. Proper timing is key to successfully preventing symptoms.
For most people who use Dimenhydrinate occasionally for travel, stopping the medication suddenly is not a problem. However, if you have been taking it daily for an extended period (several weeks), stopping abruptly may cause mild withdrawal symptoms. These can include nausea, sweating, irritability, and trouble sleeping, often referred to as 'cholinergic rebound.' If you have been using it long-term, it is best to talk to your doctor about gradually reducing your dose. They can help you taper off the medication safely.
If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, simply skip the missed dose and continue with your regular schedule. Never take two doses at the same time to make up for a missed one, as this increases your risk of side effects and toxicity. If you are using the medication only as needed for travel, you can simply take the next dose when required, provided you follow the 4-6 hour interval rule. Consult your pharmacist if you are unsure about your dosing schedule.
Dimenhydrinate is not typically associated with weight gain when used as directed for short-term motion sickness. Unlike some long-term psychiatric medications or certain other antihistamines used chronically, it does not significantly alter appetite or metabolism in most patients. However, because it causes drowsiness, some people may become less active while taking it, which could indirectly affect weight over time if used very frequently. If you notice unusual weight changes while taking this medication, you should discuss them with your healthcare provider. They can help determine if the medication or another factor is the cause.
Dimenhydrinate can interact with many other drugs, particularly those that also cause sleepiness or have anticholinergic effects. It should not be combined with other antihistamines, sleep aids, narcotic pain relievers, or muscle relaxants without a doctor's approval. It can also interfere with the effectiveness of certain medications for Alzheimer's disease or glaucoma. Always provide your healthcare provider with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking. This is the best way to prevent dangerous drug interactions.
Yes, Dimenhydrinate is widely available as a generic medication and is often much less expensive than brand-name versions like Dramamine. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drug. You can find generic Dimenhydrinate in most pharmacies and grocery stores in various forms, including tablets, chewables, and liquids. Whether you choose the brand name or the generic, the medication will work the same way in your body. Ask your pharmacist for help selecting a generic option.
Other drugs with the same active ingredient (Dimenhydrinate)